- Otsuka America Pharmaceutical Inc. (Columbus, OH)
- …activities + Deep understanding of cell culture techniques, bioreactor operations, and cell line development + Strong knowledge of cGMP regulations and ... conducted by external partners. **Key Responsibilities:** + Lead the upstream development , fostering a culture of scientific excellence, innovation, and continuous… more
- Sumitomo Pharma (Columbus, OH)
- …needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the US, Canada, and ... late-stage assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For...vision, life and disability insurances and leaves provided in line with your work state. Our robust time-off policy… more
- Sumitomo Pharma (Columbus, OH)
- …needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the US, Canada, and ... of early- to late-stage assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA,… more
- RTX Corporation (Troy, OH)
- …operators accordingly. + Work with QE's & ME's to improve processes within the cell in order to improve efficiency/eliminate rework/scrap. + Work with 1st and 3rd ... before they impact the month/quarter. + Roll-up, consolidate, speak to overall cell results (control tower ownership) + Ensure robust root cause and corrective… more
- GE Aerospace (Cincinnati, OH)
- …evaluate both vendor and in-house systems, explore new technologies, and spearhead software development efforts to advance our test cell systems. If you're ... about collaborating with a dynamic team to upgrade test cell systems to the next generation, this role is...Participate in design reviews and create technical documentation in line with engineering policies and procedures. + **Problem-Solving and… more
- Sumitomo Pharma (Columbus, OH)
- …needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the US, Canada, and ... of early- to late-stage assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA,… more
- Sumitomo Pharma (Columbus, OH)
- …needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the US, Canada, and ... late-stage assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For...SOPs, and fosters a culture of "Safety First" in line with -SMPA's values and related behaviors. **Key Core… more
- MetroHealth (Cleveland, OH)
- …and socioeconomic backgrounds Preferred: Doctorate degree in a health-related field. Experience in Service line development , business development , hospital ... Center partner institutions in the facilitation of preclinical strategies of cell therapy, including execution and regulatory compliance for manufacturing and… more
- Sumitomo Pharma (Columbus, OH)
- …needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the US, Canada, and ... late-stage assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For...vision, life and disability insurances and leaves provided in line with your work state. Our robust time-off policy… more
- Sumitomo Pharma (Columbus, OH)
- …needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the US, Canada, and ... late-stage assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For...vision, life and disability insurances and leaves provided in line with your work state. Our robust time-off policy… more